AAAAAA

   
Results: 1-10 |
Results: 10
Dopamine D-2 receptor availability and amphetamine-induced dopamine release in unipolar depression
Authors: Parsey, RV Oquendo, MA Zea-Ponce, Y Rodenhiser, J Kegeles, LS Pratap, M Cooper, TB Van Heertum, R Mann, JJ Laruelle, M
Citation: Rv. Parsey et al., Dopamine D-2 receptor availability and amphetamine-induced dopamine release in unipolar depression, BIOL PSYCHI, 50(5), 2001, pp. 313-322
Kinetic modeling of benzodiazepine receptor binding with PET and high specific activity [C-11]Iomazenil in healthy human subjects
Authors: Bremner, JD Horti, A Staib, LH Zea-Ponce, Y Soufer, R Charney, DS Baldwin, R
Citation: Jd. Bremner et al., Kinetic modeling of benzodiazepine receptor binding with PET and high specific activity [C-11]Iomazenil in healthy human subjects, SYNAPSE, 35(1), 2000, pp. 68-77
Increased baseline occupancy of D-2 receptors by dopamine in schizophrenia
Authors: Abi-Dargham, A Rodenhiser, J Printz, D Zea-Ponce, Y Gil, R Kegeles, LS Weiss, R Cooper, TB Mann, JJ Van Heertum, RL Gorman, JM Laruelle, M
Citation: A. Abi-dargham et al., Increased baseline occupancy of D-2 receptors by dopamine in schizophrenia, P NAS US, 97(14), 2000, pp. 8104-8109
Modulation of amphetamine-induced striatal dopamine release by ketamine inhumans: Implications for schizophrenia
Authors: Kegeles, LS Abi-Dargham, A Zea-Ponce, Y Rodenhiser-Hill, J Mann, JJ Van Heertum, RL Cooper, TB Carlsson, A Laruelle, M
Citation: Ls. Kegeles et al., Modulation of amphetamine-induced striatal dopamine release by ketamine inhumans: Implications for schizophrenia, BIOL PSYCHI, 48(7), 2000, pp. 627-640
Low dopamine D-2 receptor binding potential in social phobia
Authors: Schneier, FR Liebowitz, MR Abi-Dargham, A Zea-Ponce, Y Lin, SH Laruelle, M
Citation: Fr. Schneier et al., Low dopamine D-2 receptor binding potential in social phobia, AM J PSYCHI, 157(3), 2000, pp. 457-459
Protein precipitation: An expedient procedure for the routine analysis of the plasma metabolites of [I-123]IBZM
Authors: Zea-Ponce, Y Laruelle, M
Citation: Y. Zea-ponce et M. Laruelle, Protein precipitation: An expedient procedure for the routine analysis of the plasma metabolites of [I-123]IBZM, NUCL MED BI, 26(7), 1999, pp. 811-814
Synthesis of [I-123]IBZM: A reliable procedure for routine clinical studies
Authors: Zea-Ponce, Y Laruelle, M
Citation: Y. Zea-ponce et M. Laruelle, Synthesis of [I-123]IBZM: A reliable procedure for routine clinical studies, NUCL MED BI, 26(6), 1999, pp. 661-665
Quantitation of benzodiazepine receptor binding with PET [C-11]iomazenil and SPECT [I-123]iomazenil: preliminary results of a direct comparison in healthy human subjects
Authors: Bremner, JD Baldwin, R Horti, A Staib, LH Ng, CK Tan, PZ Zea-Ponce, Y Zoghbi, S Seibyl, JP Soufer, R Charney, DS Innis, RB
Citation: Jd. Bremner et al., Quantitation of benzodiazepine receptor binding with PET [C-11]iomazenil and SPECT [I-123]iomazenil: preliminary results of a direct comparison in healthy human subjects, PSYCH RES-N, 91(2), 1999, pp. 79-91
PET studies of binding competition between endogenous dopamine and the D-1radiotracer [C-11]NNC 756
Authors: Abi-Dargham, A Simpson, N Kegeles, L Parsey, R Hwang, DR Anjilvel, S Zea-Ponce, Y Lombardo, I Van Heertum, R Mann, JJ Foged, C Halldin, C Laruelle, M
Citation: A. Abi-dargham et al., PET studies of binding competition between endogenous dopamine and the D-1radiotracer [C-11]NNC 756, SYNAPSE, 32(2), 1999, pp. 93-109
Stability of [I-123]IBZM SPECT measurement of amphetamine-induced striataldopamine release in humans
Authors: Kegeles, LS Zea-Ponce, Y Abi-Dargham, A Rodenhiser, J Wang, T Weiss, R Van Heertum, RL Mann, JJ Laruelle, M
Citation: Ls. Kegeles et al., Stability of [I-123]IBZM SPECT measurement of amphetamine-induced striataldopamine release in humans, SYNAPSE, 31(4), 1999, pp. 302-308
Risultati: 1-10 |